A Randomized Trial of the Rapamycin Target Eluting Stent for the Treatment of Symptomatic Cerebral Artery Atherosclerotic Disease（TARGET-DREAM）

NCT06925971 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

279

Enrollment

INDUSTRY

Sponsor class

Conditions

Intracranial Arteriosclerosis

Interventions

DEVICE: Experimental Device A, a self-expanding rapamycin target-eluting stent (MicroPort NeuroTech, Shanghai, China)
DEVICE: Experimental Device B, a balloon-expandable rapamycin target-eluting stent (MicroPort NeuroTech, Shanghai, China)
DEVICE: Apollo® Intracranial Artery Stent System, a balloon-expandable bare-metal stent (MicroPort NeuroTech, Shanghai, China),

Sponsor

MicroPort NeuroTech Co., Ltd.